Alendronate - still an important link in the chain of osteoporosis treatment

Abstract

Alendronate (alendronate sodium) is indicated for the treatment of postmenopausal and corticoid-induced osteoporosis (OP), it reduces bone turnover rate, increases bone mineral density and preverses the quality of bone.

Keywords

• Alendronate
• osteoporosis
• studies FIT